The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

Mississauga: GSK's AREXVY (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) has been approved in Canada ...

RESVIA is Moderna's second approved product in Canada, the first mRNA vaccine against RSV, and the only one in single-dose ...

The Centers for Medicare & Medicaid Services snuck new flu, RSV and COVID data-reporting requirements for nursing homes into ...

Health Canada approves Moderna’s RSV vaccine, mRESVIA for adults aged 60 years and older: Cambridge, Massachusetts Monday, November 11, 2024, 12:00 Hrs [IST] Moderna, Inc., a le ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

Moderna has received Health Canada's approval for its respiratory syncytial virus messenger ribonucleic acid (mRNA) vaccine ...

As the holidays bring family and friends together, joyful gatherings can be followed by days and weeks of illness. Cases of ...

recommends vaccination against RSV for people in Canada aged 75 years and older, as well as those aged 60 years and older who are residents of nursing homes and other chronic care facilities.

Doctors are seeing more patients with respiratory virus symptoms, and the situation isn't likely to improve with the holidays ...

Like Alameda, Contra Costa County has mandated mask-wearing in health care facilities. However, unlike other Bay Area ...